Skip to content

A randomised, double blind, controlled study on the effect of Growing up milk on the intestinal microbiota in toddlers.

Study to explore the effect of Growing Up Milk with added prebiotics or with added prebiotics and LCPUFA on the intestinal microbiota of toddlers.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON22837
Enrollment
195
Registered
2010-01-12
Start date
2010-03-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy

Interventions

Nutritional intervention starting between the age of 12 to 36 month after birth with formula feeding in a double-blind, randomised, parallel manner.

Sponsors

Danone Research B.V.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy subjects between 1 and 3 years of age; 2. Expected study product intake of 500 – 650 ml per day; 3. Written informed consent from both parents or legal representatives.

Exclusion criteria

Exclusion criteria: 1. Being breastfed in the 4 weeks before inclusion; 2. Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps for which special subject or toddler formula is required); 3. Significant congenital abnormality that could affect the study results; 4. Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks preceding the study or expected use during the study; 5. Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements; 6. Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study.

Design outcomes

Primary

MeasureTime frame
To investigate the effect of the investigational products I and II compared to the control product on the intestinal microbiota composition in healthy toddlers.

Secondary

MeasureTime frame
1. Parent’s reported symptoms of illness (with special focus on infections); 2. Faecal secretory IgA; 3. Faecal short chain fatty acids (SCFA); 4. Faecal lactate; 5. Faecal pH.

Contacts

Public ContactTarik Hessabi

P.O. Box 7005

tarik.hessabi@danone.com+31 (0)317 467800

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)